维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Fayad LE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Ten-year follow-up after intense chemoimmunotherapy with rituximab-hyper CVAD alternating with rituximab-high dose methotrexate/cytarabine(R-MA)and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma显示文摘	Romaguera JE Fayad LE Feng L	2010	Haematol2010，150，2：	1
2	Chordal cutting technique through aortotomy: a new approach to treat chronic ischemicmitral regur- gitation 显示文摘	Fayad G Modine T Le Tourneau T	2005	J Thorae Cardiovasc Surg2005，129，5：	1
3	Phase 2 study of gemeitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma 显示文摘	Oki Y Pro B Fayad LE	2008	Cancer2008，112，4：	1
4	Dose-related safety and immunogenicity of baculovirus - expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non- Hodgkin B cell lymphoma显示文摘	Safdar A Rodriguez MA Fayad LE	2006	J Infect Dis2006，194，10：	1
5	Phase 2 Study of Gemcitabine in Combination With Rituximab in Patients With Recurrent or Refractory Hodgkin Lymphoma显示文摘	Oki Y Pro B Fayad LE	2008	Cancer2008，112，4：	1
6	Phase I study of bortezomib plus ICE(BICE)for the treatment of relapsed/refractory Hodgkin lymphoma显示文摘	Fanale MA Fayad LE Pro B	2011	Br J Heamotol2011，153，：	1
7	Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma显示文摘	Romaguera JE Fayad LE Feng L	2010	Br J Haematol2010，150，：	1
8	Experience with boroezomid for the tneatment of patients with relapsad classical Hodgkin Lymphoma显示文摘	YounesA ProB Fayad LE	2008	Blood2008，109，：	1
9	Phase 2 study of gemcitabine in combi- nation with rituximab in patients with recurrent or refractory Hodgkin lymphoma显示文摘	Oki Y Pro B Fayad LE	2008	Cancer2008，112，4：	1
10	Prognostic Value of MYC Rear- rangement in Cases of B-Cell Lympboma, Unclassifiable, With Fea-tures intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma显示文摘	Lin P Dickason TJ Fayad LE	2012	Cancer2012，11，6：	1
11	B-ceillymphomas with MYC/8q24 rearrangements and IGH @ BCl2/t ( 14; 18) ( q32; q21 ): an aggressive disease with heterogeneous histology, germinal center B?cell immunophenotype and poor outcome显示文摘	Li S Lin P Fayad LE	2012	Mod Pathol2012，25，1：	1
12	Prognostic value of MYC rear- rangement in cases of B-cell lymphoma, unclassifiable, with fea- tures intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma显示文摘	Lin P Dickason TJ Fayad LE		Cancer0，118，6：	1
13	Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-hodgkin lymphoma显示文摘	Oki Y MeLaughlin P Fayad LE	2007	Cancer2007，109，1：	1
14	B-celllymphomas with MYC/8q24 rearrangements and IGH@BCL2/t (14;18) (q32;q21): an aggressive disease with heterogeneous histology, germinal center B- cell immunophenotype and poor outcome 显示文摘	Li S Lin P Fayad LE	2012	Mod Patho12012，25，：	1
15	B-cell lymphomas with MYC/Bq24 rearranBements and IGH~BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome显示文摘	Li S Lin P Fayad LE	2012	Modern Pathol2012，25，1：	1
16	Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma 显示文摘	Oki Y Pro B Fayad LE	2008	Cancer2008，112，4：	1
17	B-cell lymphomas with MYC/Sq24 rear- rangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunopheno- type and poor outcome 显示文摘	Li S Lin P Fayad LE	2012	Modem Pathology2012，25，1：	1
18	Ten-year follow-up after intense chemoimmunotherapy with Rituximab-Hyper CVAD alternating with rituximab-high dose methotrexate/ cytarabine 0R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma 显示文摘	Romaguera JE Fayad LE Feng L	2010	Br J Haematol2010，150，2：	1
19	A phase I study of bortezomib in combination with ICE(BICE)in patients with relapse/refractory classical Hodgkin's lymphoma显示文摘	Fanale MA Fayad LE Pro B	2008	Blood2008，112，：	1
20	Recent advances in de novo CD5+diffuse large B cell lymphoma 显示文摘	Jain P Fayad LE Rosenwald A	2013	Am J Hematol2013，88，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示